These findings indicate that ASPN is found in the TME of HER2/HER3-expressing metastatic prostate cancer, thereby supporting a role for the ASPN-HER2/HER3 signaling axis in metastatic prostate cancer. The gene discussed is ERBB3; the disease is metastatic prostate carcinoma.